Xarelto Lawsuit Update: New Internal Bleeding Lawsuit Filed in Vermont

September 17, 2015 – – BloodThinnerHelp.com reports today on one of the more recently filed Xarelto lawsuits. This lawsuit was filed by the daughter of a deceased man who was prescribed Xarelto to treat his atrial fibrillation and prevent blood clots and stroke. According to the complaint, he was prescribed Xarelto on July 17, 2012 and took the drug regularly until he was hospitalized for a parenchymal hemorrhage. Since he was taking Xarelto at the time, his blood was not able to clot during the hemorrhage which led to an uncontrollable internal bleeding event. After six days in the hospital, he passed away from internal bleeding complications on August 1, 2012. The lawsuit alleges that Xarelto was the cause of the man’s internal bleeding event and death. This case was filed on July 25, 2014 in Vermont federal court under the case number 2:14-CV-00159-CR. You can download and read the full complaint here.

Xarelto Linked to Serious Internal Bleeding:

In this case, the man suffered from a parenchymal hemorrhage, a very severe brain bleed. It is an immediate medical emergency and can be caused by high blood pressure or some kind of trauma. The excessive bleeding in the brain compresses brain tissue and can cut off the brain’s oxygen supply. If a drug such as Xarelto is in the patient’s system, as it was in this case, it completely prevents the blood from clotting. A parenchymal hemorrhage is often difficult to treat and requires extreme life saving measures because detection of the condition usually happens too late. You can find more information about different types of brain bleeds here.

Xarelto Lawsuits Allege The Drug Is Dangerous:

The plaintiff in Vermont is bringing this lawsuit forward as the administrator of the deceased’s estate. She is seeking damages for medical expenses, probate, attorney fees, funeral expenses, pain and suffering, and other expenses related to his estate. The complaint notes that if the plaintiff and her father were aware of the real risks that Xarelto usage posed, they would have chosen one of the safer alternatives available on the market. The complaint alleges that the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, the pharmaceutical division of Johnson&Johnson, were reckless by releasing the drug onto the market.

Xarelto is a much more dangerous drug than traditional blood thinners, such as Warfarin, because there is no antidote available to reverse its anticoagulant effects. If a patient experiences an internal bleeding event and is taking Warfarin, a doctor will be able to administer vitamin K to the patient and their blood will clot again. If a patient is taking Xarelto and experiences an internal bleed, there is no way to stop the bleeding, which often leads to an uncontrollable internal bleeding event and serious injury.

“As the Xarelto litigation moves forward, we expect to see even more cases filed across the country,” Xarelto attorney Marc Goldich said. “We strongly encourage anyone who feels that they have been harmed by Xarelto usage to contact us immediately.”

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60004237